Bausch + Lomb Shares Outstanding 2021-2025 | BLCO
Bausch + Lomb shares outstanding history from 2021 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Bausch + Lomb shares outstanding for the quarter ending March 31, 2025 were 0.353B, a 0.48% increase year-over-year.
- Bausch + Lomb 2024 shares outstanding were 0.352B, a 0.37% increase from 2023.
- Bausch + Lomb 2023 shares outstanding were 0.351B, a 0.09% increase from 2022.
- Bausch + Lomb 2022 shares outstanding were 0.35B, a 0.06% increase from 2021.
| Bausch + Lomb Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 352 |
| 2023 | 351 |
| 2022 | 350 |
| 2021 | 350 |
| 2020 | 350 |
| Bausch + Lomb Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 353 |
| 2024-12-31 | 352 |
| 2024-09-30 | 354 |
| 2024-06-30 | 352 |
| 2024-03-31 | 351 |
| 2023-12-31 | 351 |
| 2023-09-30 | 351 |
| 2023-06-30 | 351 |
| 2023-03-31 | 350 |
| 2022-12-31 | 350 |
| 2022-09-30 | 350 |
| 2022-06-30 | 350 |
| 2022-03-31 | 350 |
| 2021-12-31 | 350 |
| 2021-09-30 | 350 |
| 2021-06-30 | 350 |
| 2021-03-31 | 350 |
| 2020-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $5.183B | $4.791B |
| Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.115B | 27.47 |
| CVS Health (CVS) | United States | $75.901B | 9.43 |
| Elevance Health (ELV) | United States | $65.016B | 8.74 |
| Cencora (COR) | United States | $56.164B | 19.54 |
| DiDi Global (DIDIY) | China | $25.650B | 27.25 |
| Labcorp Holdings (LH) | United States | $21.906B | 17.29 |
| Natera (NTRA) | United States | $18.548B | 0.00 |
| BioMerieux (BMXMF) | France | $17.068B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.156B | 0.00 |
| ICON (ICLR) | Ireland | $14.957B | 14.39 |
| CochLear (CHEOY) | Australia | $13.609B | 0.00 |
| Solventum (SOLV) | United States | $12.725B | 13.47 |
| Medpace Holdings (MEDP) | United States | $12.583B | 33.30 |
| Revvity (RVTY) | United States | $11.135B | 19.32 |
| Viatris (VTRS) | United States | $10.786B | 3.71 |
| Avantor (AVTR) | United States | $9.547B | 13.87 |
| Sonic Healthcare (SKHHY) | Australia | $9.074B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.765B | 17.17 |
| HealthEquity (HQY) | United States | $8.282B | 36.28 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.001B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.058B | 27.69 |
| BrightSpring Health Services (BTSG) | United States | $3.534B | 32.42 |
| Sotera Health (SHC) | United States | $3.446B | 19.58 |
| Surgery Partners (SGRY) | United States | $2.862B | 37.22 |
| Organon (OGN) | United States | $2.636B | 2.80 |
| GeneDx Holdings (WGS) | United States | $2.619B | 60.38 |
| Concentras Parent (CON) | United States | $2.589B | 14.96 |
| Alignment Healthcare (ALHC) | United States | $2.331B | 0.00 |
| Progyny (PGNY) | United States | $1.957B | 43.08 |
| PACS (PACS) | United States | $1.757B | 0.00 |
| Premier (PINC) | United States | $1.749B | 13.27 |
| GoodRx Holdings (GDRX) | United States | $1.739B | 34.79 |
| Ardent Health (ARDT) | United States | $1.532B | 6.53 |
| Teladoc Health (TDOC) | United States | $1.321B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.192B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.088B | 8.28 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.875B | 300.00 |
| Agilon Health (AGL) | United States | $0.799B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.740B | 6.93 |
| CareDx (CDNA) | United States | $0.708B | 11.06 |
| Embecta (EMBC) | United States | $0.628B | 4.23 |
| So-Young (SY) | China | $0.507B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.489B | 0.00 |
| Nutex Health (NUTX) | United States | $0.474B | 7.18 |
| Sonida Senior Living (SNDA) | United States | $0.469B | 0.00 |
| Omada Health (OMDA) | $0.468B | 0.00 | |
| LifeMD (LFMD) | United States | $0.464B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.456B | 10.27 |
| SBC Medicals (SBC) | United States | $0.454B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.401B | 0.00 |
| Enhabit (EHAB) | United States | $0.337B | 27.75 |
| Oncology Institute (TOI) | United States | $0.323B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.276B | 0.00 |
| Beauty Health (SKIN) | United States | $0.213B | 0.00 |
| DocGo (DCGO) | United States | $0.145B | 23.67 |
| Sera Prognostics (SERA) | United States | $0.109B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
| KindlyMD (NAKA) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.057B | 0.00 |
| ModivCare (MODV) | United States | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.042B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.040B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.018B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |